Cardiol Therapeutics Announces Year-End 2022 Update on Operations
Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart... | March 29, 2023